Key result
Percutaneous left atrial appendage closure using an embolic protection device was successfully performed without complications in 1 patient with recurrent embolisms despite adequate anticoagulation.
Why the study?
Antithrombotic management in patients with atrial fibrillation who have undergone heart valve surgery is challenging, particularly when thromboembolic events occur despite follow-up anticoagulation.
Population
One 66-year-old female with AF and mechanical aortic and mitral valve replacement
Design
Case report
Authors
Loading...
Supports feasibility of combined antithrombotic and transcatheter strategies in complex post-valve AF; leaves open need for prospective evaluation.
Case Report (n=1)
Percutaneous left atrial appendage closure with an embolic protection device may be a feasible adjunctive strategy for patients with atrial fibrillation and mechanical valves who suffer recurrent thromboembolic events despite adequate anticoagulation.
Marschall et al. (2021) conducted a case report in Atrial fibrillation and prosthetic heart valves with recurrent embolisms (n=1). Percutaneous left atrial appendage closure with embolic protection device was evaluated. Percutaneous left atrial appendage closure using an embolic protection device was successfully performed without complications in 1 patient with recurrent embolisms despite adequate anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: